Reading the graph
Christian Angermayer (majority shareholder of Apeiron) family
Sliema
Apeiron Investment Group is a discretionary investment firm founded and owned by serial entrepreneur and investor Christian Angermayer.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures, dfx's own graph. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Target | State | Kind | Asset class | Sector | Announced | Amount | Evidence |
|---|---|---|---|---|---|---|---|
| Enhanced Group Inc. (NYSE: ENHA) $50M PIPE | n/a | Round participation | Growth equity | Sports and consumer health | Jun 15, 2026 | $50.0M | fact |
| Enhanced Group | n/a | pipe | Public equity | n/a | Jun 15, 2026 | n/a | fact |
| Enhanced Group | n/a | pipe | Public equity | n/a | Jun 15, 2026 | n/a | fact |
| Enhanced Group | n/a | Round participation | n/a | n/a | Jun 15, 2026 | n/a | fact |
| Enhanced Group Inc. working capital note (up to $20.0M line of credit) | n/a | credit | Private credit | Sports and consumer health | May 7, 2026 | $20.0M | fact |
| Enhanced Group Inc. (Enhanced Ltd. de-SPAC with A Paradise Acquisition Corp.) | n/a | Direct investment | venture | Sports and consumer health | May 7, 2026 | n/a | fact |
| atai Life Sciences N.V. | n/a | public equity stake | public equities | biotech / life sciences | Oct 20, 2025 | n/a | fact |
| atai Life Sciences N.V. | n/a | public company stake built via PIPE financings and open-market purchases | public equities | biopharma / mental health | Jul 1, 2025 | $50.0M | fact |
| ATAI Life Sciences N.V. (February 2025 registered offering) | n/a | Round participation | other | Psychedelic mental health biotech | Feb 14, 2025 | $22.8M | fact |
| Bionomics Limited (via Apeiron Presight Capital Fund II) | n/a | venture | venture | Neuropsychiatry biotech | Oct 3, 2024 | n/a | fact |
| Palo Santo | n/a | Direct investment | n/a | n/a | Sep 21, 2021 | n/a | fact |
| Rezolve Limited (pre-SPAC shareholder) | n/a | venture | venture | AI commerce | Dec 18, 2018 | n/a | fact |
| Rejuveron Life Sciences and Cambrian Biopharma | n/a | venture | venture | Longevity biotech | n/a | n/a | fact |
| Sensei Biotherapeutics, Inc. (pre-IPO and IPO shares) | n/a | venture | venture | Immuno-oncology biotech | n/a | $27.4M | fact |
| Plasma (XPL) seed round | n/a | venture | venture | Stablecoin blockchain | n/a | n/a | fact |
| Elevat3 (Apeiron venture vehicle, Peter Thiel anchor) | n/a | venture | venture | DACH startups | n/a | n/a | fact |
| Interactive Strength, Inc. (Forme) investor rights | n/a | venture | venture | Connected fitness | n/a | n/a | fact |
| Alto Neuroscience, Inc. (Series A and B preferred, pre-IPO) | n/a | venture | venture | Precision psychiatry biotech | n/a | n/a | fact |
| Presight Capital Fund I ($80M) | n/a | venture | venture | International venture | n/a | $80.0M | fact |
| atai Life Sciences (founded 2018) | n/a | venture | venture | Psychedelic mental health biotech | n/a | n/a | fact |
| Person | Title | Role | Seniority | Family member | Current | Evidence |
|---|---|---|---|---|---|---|
| Fabian Hansen | Co-founder, Presight Capital (reporting person for Presight Capital Fund II) | venture | unknown | no | yes | fact |
| Christian Angermayer | Founder | leadership | senior | n/a | yes | fact |
| Mario Frendo | Sole director and Senior Legal Counsel, Apeiron | leadership | senior | no | yes | fact |
| Christian Angermayer | Founder | Family principal | senior | yes | yes | fact |
| Jefim Gewiet | Director and managing director, Apeiron Investment Group Ltd (2022); financial advisor | operations | unknown | no | no | fact |
| Julien Hoefer | Director and managing director, Apeiron Investment Group Ltd (2022); lawyer | leadership | senior | no | no | fact |
Apeiron Investment Group (probable sfo, state unknown) announced or transacted 7 private investments in 5 companies between 2025-10-20 and 2026-06-15. Recent: Enhanced Group, Enhanced Group, Enhanced Group.
Also named here, with no published line of their own (reach them through the firm): Christian Angermayer (Founder), Fabian Hansen (Co-founder, Presight Capital (reporting person for Presight Capital Fund II)), Mario Frendo (Sole director and Senior Legal Counsel, Apeiron).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan